Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Heartbeam, Inc. - Common Stock (NQ: BEAT ) 2.260 -0.090 (-3.83%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 210,475 Open 2.390 Bid (Size) 2.230 (2) Ask (Size) 2.500 (2) Prev. Close 2.350 Today's Range 2.210 - 2.390 52wk Range 1.350 - 3.480 Shares Outstanding 34,260,799 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at JP Morgan 2025 Annual Healthcare Conference December 23, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference December 23, 2024 From HeartBeam, Inc. Via Business Wire Performance YTD -3.00% -3.00% 1 Month -20.70% -20.70% 3 Month -2.16% -2.16% 6 Month -12.06% -12.06% 1 Year -9.60% -9.60% More News Read More HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology December 16, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device December 16, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Positive Data for Groundbreaking Technology at AHA Conference November 19, 2024 Via Investor Brand Network HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference November 19, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Technology with FDA Submissions and Key Leadership Appointments November 08, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety HeartBeam Reports Third Quarter 2024 Results November 07, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates October 31, 2024 Via Investor Brand Network Topics Earnings Intellectual Property Exposures Financial Intellectual Property HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time October 31, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care October 24, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards October 24, 2024 From HeartBeam, Inc. Via Business Wire Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader CEO: Heartbeam, Inc. (NASDAQ: BEAT) October 17, 2024 Via Get News Topics Artificial Intelligence Exposures Artificial Intelligence TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Robert Eno as New CEO to Lead Next Phase of Growth and Innovation October 17, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization October 17, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Industry Expert, Pioneer as New Chief AI Scientist September 24, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist September 24, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Industry Expert as New CFO September 10, 2024 Via Investor Brand Network Topics Intellectual Property Retirement Exposures Intellectual Property Pension HeartBeam Names Timothy Cruickshank as Chief Financial Officer September 10, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update August 15, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety BEAT Stock Earnings: HeartBeam Misses EPS for Q2 2024 August 14, 2024 Via InvestorPlace HeartBeam Reports Second Quarter 2024 Results August 14, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results August 01, 2024 Via Investor Brand Network HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time August 01, 2024 From HeartBeam, Inc. Via Business Wire BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index July 01, 2024 Via Investor Brand Network Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
